3
Announcements
Trials
Browse
Landscape
Status
Completed
12
Recruiting
6
Unknown
2
Terminated
2
Active not recruiting
2
No longer available
1
Available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Multiple Myeloma
15
Melanoma
14
Carcinoma, Non-Small-Cell Lung
13
Recurrence
12
Neoplasms
12
Leukemia, Myeloid, Acute
9
Glioblastoma
8
Prostatic Neoplasms
6
Lung Neoplasms
6
Breast Neoplasms
6
Lymphoma
5
Glioma
5
Carcinoma, Renal Cell
5
Sarcoma
4
Pancreatic Neoplasms
4
Lymphoma, Non-Hodgkin
4
Gastrointestinal Stromal Tumors
4
Colorectal Neoplasms
4
Triple Negative Breast Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Carcinoma
3
Solid Tumors
2
Small Cell Lung Carcinoma
2
Ovarian Neoplasms
2
Neoplasms by Site
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Large-Cell, Anaplastic
2
Liver Neoplasms
2
Leukemia
2
Interventions
midostaurin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
No longer available
×
INDUSTRY
×
Mastocytosis, Systemic
×
Clear all
NCT05219266
2024-06-28
Managed Access Programs for PKC412, Midostaurin
Novartis
No longer available